Cheers to USCAP 2025: Recapping The Momentum, Insights, and Inspiration

Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s Pipeline and Accelerate Global...

PathAI: Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs  SECAUCUS, N.J. and BOSTON –...

Nijmegen, the Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the integration of its innovative mitosis detection algorithm, Aiosyn...

Linköping, Sweden – April 29, 2024 – International medical imaging IT and Cybersecurity company Sectra’s (STO: SECT B) digital pathology solution together with Leica Biosystems, Imaging, Inc.’s Aperio GT 450 DX have received a 510(k)...

From Cytomine: JOIN US IN VILNIUS FOR ECDP 2024 We are excited to invite you to the 20th European Conference on Digital Pathology (ECDP) in Vilnius, Lithuania. Why you should attend We will...

Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has  received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement...